One of the notable differences between pregnancy before 35 and pregnancy at 35 or older is the expanded conversation around prenatal testing. Women who are 35 or older at the time of delivery are sometimes classified as “advanced maternal age” (AMA) in clinical settings — a term that, while clinical rather than judgmental, can feel alarming. Associated with this classification is an increased emphasis on prenatal screening and diagnostic testing, particularly for chromosomal conditions.
Navigating the world of prenatal testing can feel overwhelming. There are multiple tests, each with different purposes, limitations, and implications. Some are screening tests that assess probability; others are diagnostic tests that can provide more definitive answers. Understanding the difference — and what each test can and cannot tell you — is valuable for making informed decisions.
This article provides an overview of common prenatal tests relevant to women 35 and older, with an emphasis on what each test does, what it doesn’t do, and what questions are worth raising with your healthcare provider.
Why Prenatal Testing Discussions Change After 35
The primary reason prenatal testing conversations expand after 35 is the age-related increase in the risk of chromosomal conditions, most notably Down syndrome (trisomy 21). According to the American College of Obstetricians and Gynecologists (ACOG), the risk of chromosomal abnormalities increases gradually with maternal age — not dramatically, but meaningfully enough to warrant informed discussion.
At age 35, the risk of having a baby with Down syndrome is approximately 1 in 350. By age 40, it’s approximately 1 in 100. These statistics describe population-level risk, not individual outcomes — and importantly, the vast majority of pregnancies at these ages result in chromosomally typical babies. The decision about whether and which testing to pursue is personal, and there is no universally “right” answer.
It’s also worth noting that ACOG guidelines now indicate that all pregnant women — not just those over 35 — should be offered both screening and diagnostic testing options. The 35 threshold was a historical one that has been partly revised in clinical thinking, though age remains a relevant factor in risk conversations.
Screening Tests: What They Assess and What They Can’t Tell You
Screening tests are designed to assess probability — they don’t diagnose conditions. A positive or “high-risk” screening result doesn’t mean a baby has a chromosomal condition; it means further evaluation is warranted. Conversely, a low-risk result doesn’t guarantee a baby is unaffected. This distinction is critical and is sometimes poorly communicated in clinical settings.
Cell-Free DNA (cfDNA) Screening / NIPT
Non-invasive prenatal testing (NIPT), also called cell-free DNA screening, analyzes small fragments of fetal DNA circulating in the mother’s blood. It can assess the probability of chromosomal conditions including trisomy 21 (Down syndrome), trisomy 18 (Edwards syndrome), trisomy 13 (Patau syndrome), and sex chromosome abnormalities. NIPT has high sensitivity and specificity compared to other screening tests, though it remains a screening test — it does not diagnose.
For women over 35, NIPT is commonly offered because its performance characteristics are particularly valuable in a higher-risk population. However, even with NIPT, a “high-risk” result should be followed by diagnostic testing (amniocentesis or CVS) for confirmation. Some direct-to-consumer NIPT offerings exist, but these are generally best interpreted in clinical context. For background on navigating the emotional dimensions of this testing, our article on anxiety during pregnancy after 35 may offer helpful context.
First Trimester Combined Screening
This approach combines a blood test (measuring PAPP-A and hCG) with an ultrasound measurement of nuchal translucency (the fluid at the back of the baby’s neck). Together, these provide a risk assessment for chromosomal conditions. First trimester combined screening is typically performed between 11 and 13 weeks. Detection rates are lower than NIPT for the same conditions, but it can provide additional information including markers for other conditions.
Quad Screen (Second Trimester)
The quad screen is a blood test performed in the second trimester (typically 15-22 weeks) that measures four substances in the mother’s blood. It screens for Down syndrome, trisomy 18, and neural tube defects. Like other screening tests, it provides probability assessments rather than diagnoses. It’s sometimes used when first trimester screening wasn’t performed.
Diagnostic Tests: What They Can Tell You
Diagnostic tests — primarily amniocentesis and chorionic villus sampling (CVS) — can provide definitive chromosomal information, but they carry small procedural risks. Understanding the distinction between screening and diagnostic testing is one of the most important aspects of prenatal testing conversations for women over 35.
Chorionic Villus Sampling (CVS)
CVS involves removing a small sample of placental tissue, typically between 10-13 weeks of pregnancy. It can provide definitive chromosomal analysis, including full karyotyping and targeted testing. CVS can be performed earlier than amniocentesis, which some women prefer if they wish to have diagnostic information in the first trimester. The procedural risk of pregnancy loss is estimated at approximately 0.5-1% depending on the provider’s experience, though some research suggests complication rates with experienced practitioners are lower.
Amniocentesis
Amniocentesis involves removing a small amount of amniotic fluid, typically between 15-20 weeks. It provides definitive chromosomal analysis and can test for a range of genetic conditions. The procedural risk of pregnancy loss is estimated at approximately 0.1-0.3% with experienced practitioners. Amniocentesis results are highly accurate and can provide detailed chromosomal information beyond what screening tests offer. For broader context about pregnancy after 35, our comprehensive guide covers many aspects of the journey.
Making Informed Decisions About Testing
The decision about whether to pursue prenatal testing — and which tests — is deeply personal and depends on values, circumstances, and individual health factors. Some women want the most complete information possible; others prefer not to know probability estimates that may cause anxiety without changing their intentions. Both positions are valid, and respected.
Healthcare providers can present the options clearly, but the decision belongs to the woman and her partner. Some questions that may be helpful in these conversations include:
- What would I do with a high-risk screening result? Would I want diagnostic testing to confirm?
- What would I do if a diagnostic test confirmed a chromosomal condition? Would this affect my pregnancy decisions?
- How do I feel about the procedural risk of diagnostic testing relative to the information it would provide?
- Do I want to know this information early (first trimester) or is timing less critical to me?
Genetic counselors — specialists trained in interpreting genetic testing and helping patients navigate testing decisions — can be an invaluable resource. Many maternal-fetal medicine practices have genetic counselors available, and some insurance plans cover these consultations during pregnancy.
Anatomy Ultrasound and Structural Screening
Beyond chromosomal testing, a detailed anatomy ultrasound (typically performed around 18-20 weeks) assesses fetal structural development. This ultrasound examines major organ systems, limb development, and various anatomical markers. While not specific to women over 35, it’s a standard component of prenatal care that many women find valuable. Some women over 35 may also have additional ultrasound monitoring recommended based on individual health factors.
Frequently Asked Questions
Is prenatal testing required for women over 35?
No prenatal testing is required or mandatory. ACOG’s current position is that all pregnant women should be offered — but not required to have — both screening and diagnostic testing options. The decision is personal and should be made with informed understanding of what each test can and cannot provide.
How accurate is NIPT?
NIPT has high sensitivity (ability to correctly identify affected pregnancies) and specificity (ability to correctly identify unaffected pregnancies) compared to other screening tests — particularly for Down syndrome. However, false positives and false negatives do occur, particularly for rarer conditions. NIPT results should be interpreted with a healthcare provider and, if high-risk, followed by diagnostic testing for confirmation.
What is the risk of miscarriage from amniocentesis?
Estimates vary by study and provider experience, but contemporary data from experienced practitioners generally cite miscarriage risk in the range of 0.1-0.3%. For women 35 and older, this risk is sometimes compared to the age-related risk of chromosomal conditions to help inform decision-making, though this comparison is one of many factors to consider.
When should I see a genetic counselor?
Genetic counseling is worth considering before or after any prenatal testing, particularly if results are abnormal or ambiguous, if there is a personal or family history of genetic conditions, or if you want a thorough explanation of your testing options before deciding. Many maternal-fetal medicine practices offer genetic counseling as part of comprehensive prenatal care for women over 35.
Key Takeaways
- Prenatal testing conversations expand after 35 primarily because of the age-related increase in chromosomal condition risk — though the majority of pregnancies at all ages over 35 result in healthy babies.
- Screening tests (including NIPT, first trimester combined screening, and quad screen) assess probability — they don’t diagnose. A high-risk result warrants further evaluation, not a conclusion.
- Diagnostic tests (CVS, amniocentesis) provide definitive chromosomal information but carry small procedural risks that should be weighed in individual decision-making.
- Decisions about prenatal testing are personal and depend on values, circumstances, and what individuals would do with the information — all are valid choices.
- Genetic counselors can be a valuable resource for navigating testing decisions, interpreting results, and considering implications.
Medical Disclaimer
This content is for informational purposes only and does not constitute medical advice. Individual health situations vary significantly. Always consult a qualified healthcare provider before making decisions related to your health, fertility, or pregnancy.
About the Author
Emily Carter is a women’s health writer focused on fertility, pregnancy after 35, and sleep changes in midlife. She writes research-informed, non-alarmist content to help women navigate reproductive and hormonal transitions with clarity and confidence.